Drug Profile
ABX 1488
Alternative Names: [18F]ABX-1488Latest Information Update: 28 Jun 2019
Price :
$50
*
At a glance
- Originator Abide Therapeutics
- Class Radiopharmaceutical diagnostics
- Mechanism of Action Monoacylglycerol lipase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders
Most Recent Events
- 28 Jun 2019 No recent reports of development identified for phase-I development in Neurological-disorders(Diagnosis, In volunteers) in Unknown